Literature DB >> 1215947

[The pharmacokinetics of doxycycline in kidney insufficiency in geriatric patients compared to younger adults].

C Simon, V Malerczyk, H Engelke, I Preuss, H Grahmann, K Schmidt.   

Abstract

In young adults i.v. injection of 200 mg doxycycline was followed by a rapid fall in serum levels in the first 30 minutes and than a slow decrease (serum concentration after 24 h on average 1.0 mug/ml). Biological half-life was 11.9 h, final distribution volume 50.0 litres and urine recovery 70%. After oral administration of 200 mg doxycycline the serum peaks measured were 3.4 mug/ml (2 1/2 h later). With repeated doses of 100 mg every 24 h serum peaks were 2.8 mug/ml and serum concentrations after 24 h 0.8-0.9 mug/ml (urine recovery 43%). The area under the curve was 25.5% less than after i.v. injection. In 7 adults with chronic renal failure the half-life of doxycycline varied between 10 and 24 h. With repeated oral administration of doxycycline (100 mg every 24 h) there was no accumulation of the drug in blood. During hemodialysis (Stuttgart kidneys, Rhône-Poulenc plates) doxycycline injected i.v. was eliminated as rapidly as before. In renal failure doxycycline may be given in the same dosage as where renal function is normal. In 12 geriatric patients without renal disease, serum levels of doxycycline after i.v. injection of 200 mg were not significantly different from those of young adults (distribution volume 46.2 +/- 16.2 litres). It can therefore be assumed that tissue penetration of the drug is similar in the elderly and in young adults.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1215947

Source DB:  PubMed          Journal:  Schweiz Med Wochenschr        ISSN: 0036-7672


  3 in total

Review 1.  Antibiotic therapy in aging patients.

Authors:  S R Norrby
Journal:  Bull N Y Acad Med       Date:  1987 Jul-Aug

2.  The effects of chronic renal insufficiency on the pharmacokinetics of doxycycline in man.

Authors:  G Houin; F Brunner; T Nebout; M Cherfaoui; G Lagrue; J P Tillement
Journal:  Br J Clin Pharmacol       Date:  1983-09       Impact factor: 4.335

3.  Serum level, half-life and apparent volume of distribution of doxycycline in geriatric patients.

Authors:  R Böcker; W Mühlberg; D Platt; C J Estler
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.